Cardiac Malformations Are Increased in Infants of Mothers with Epilepsy
Authors:
- 8 January 2008
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 29 (3) , 604-608
Abstract
We aimed to ascertain the prevalence of cardiac malformation (CM) and its association with antenatal exposure to an antiepileptic drug (AED) in infants of mothers with epilepsy (IMEs). Women with epilepsy (WWE) are enrolled in Kerala Registry of Epilepsy and Pregnancy (KREP) in the prepregnancy or early pregnancy period and are followed up with a standard protocol until the IMEs are 6 years old. At 3 months postpartum, a cardiologist, blinded to the AED exposure, carried out a clinical examination and echocardiography on all live-born babies. Patent foramen ovale (PFO) and interatrial septal defects of < 5 mm in size were excluded from CM. Details of maternal epilepsy, folate usage, AED exposure in the first trimester, and newborn characteristics were abstracted from the records of the KREP. We examined 462 babies. Maternal epilepsy was generalized in 201 (43.50%) or localization related in 241 (52.2%). The AED exposure was monotherapy in 262 (56.7%)—carbamazepine (112), valproate (71), phenobarbitone (43), phenytoin (31), and clonazepam (2)—and polytherapy in 126 (27.3%). Seventy-four infants (16.01%) had no AED exposure. There were 36 infants with CM (7.8%; 95% confidence interval: 5.5–10.6). CMs included atrial septal defect (26; 72.2%), tetrology of Fallot (3; 8.3%), patent ductus arteriosus and pulmonic stenosis (2 each; 5.6%), and ventricular septal defect, tricuspid regurgitation, transposition of great arteries (1 each; 2.8%). CMs were significantly more for IMEs with premature birth (p < .003). There was no association between CM and maternal age, epilepsy syndrome, seizure frequency during pregnancy, and folate use. CMs were more frequent with polytherapy (13; 10.3%) compared to monotherapy (17; 6.5%). Those with valproate exposure had a trend (not statistically significant) toward higher frequency of CM compared to IMEs on other AEDs as monotherapy.Keywords
This publication has 29 references indexed in Scilit:
- Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy RegisterJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Complex cardiac defect with hypoplastic right ventricle in a fetus with valproate exposurePrenatal Diagnosis, 2005
- Folic Acid Antagonists during Pregnancy and the Risk of Birth DefectsNew England Journal of Medicine, 2000
- Incidence of Structural Cardiac Disorders in Neonates: An Evaluation by Color Doppler Echocardiography and the Results of a 1-Year Follow-UpCardiology, 1995
- Genetic study of congenital heart defects in Northern Ireland (1974-1978).Journal of Medical Genetics, 1994
- Teratogenic Effects of Antiepileptic Drugs: Implications for the Management of Epilepsy in Women of Childbearing AgeEpilepsia, 1994
- Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.Archives of Disease in Childhood, 1993
- Epilepsy and pregnancy.BMJ, 1993
- Causes of death in neonates born with a heart malformationInternational Journal of Cardiology, 1986
- Congenital Heart Disease in 56,109 Births Incidence and Natural HistoryCirculation, 1971